Sort
146,196 grants matching “diabetes”
New Ulm at HOME - (NU-HOME)
$695,694Jayne Allyn Fulkerson · University Of Minnesota · R01 · FY2016 · HL
Clinical Step Recorder
$695,678Matthew D Tarler · Cleveland Medical Devices, Inc. · R44 · FY2006 · HL
Role of proteolytic suPAR fragment in insulin dependent diabetes and kidney disease
$695,626Sanja Sever · Massachusetts General Hospital · R01 · FY2023 · DK
Proteomic determinants of direct measures of insulin sensitivity
$695,603Themistocles Leonard Assimes · Stanford University · R01 · FY2020 · DK
Epidemiological and Genetic Studies of Body Mass Index
$695,588Boston University Medical Campus · R01 · FY2003 · HL
Promoting Lifestyle Change via Tailored mHealth to Improve Health
$695,581Lora E Burke · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · HL
Molecular Mechanisms Regulating Endothelial Dysfunction
$695,580Hong Chen · Boston Children'S Hospital · R01 · FY2017 · HL
Mechanisms of VSM dysfunction in diabetes and HFpEF
$695,543Manuel F Navedo · University Of California At Davis · R01 · FY2025 · HL
Asthma symptom perception feedback intervention for ethnic minority adolescents
$695,535Jonathan M. Feldman · Albert Einstein College Of Medicine, Inc · R01 · FY2019 · HL
Understanding and addressing risks of low socioeconomic status and diabetes for heart failure
$695,533Chiadi E Ndumele · Johns Hopkins University · P50 · FY2021 · MD
Emotional Distress in a Comparative Effectiveness Trial of Diabetes Treatments
$695,531Heidi Krause-Steinrauf · George Washington University · R01 · FY2015 · DK
Effects of Glycoxidative Stress on Human Aging
$695,519Helen Vlassara · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · DK
Impact of a Healthy Checkout Policy on Healthfulness of Grocery Environments and Sales
$695,497Jennifer Falbe · University Of California At Davis · R01 · FY2025 · DK
TB Aftermath
$695,483Jonathan E Golub · Johns Hopkins University · R01 · FY2020 · AI
Preclinical validation of ABHD5 as a target for treatment of obesity.
$695,461James G Granneman · Wayne State University · R01 · FY2016 · DK
SMI Dual Eligibles and Medicare Part D: Impact on Medications Continuity and Outc
$695,453Donald M Steinwachs · Johns Hopkins University · R01 · FY2010 · MH
Peptide-coated skin substitutes for the treatment of burn injuries and wounds
$695,448Bruce Lamb · Affinergy, Llc · R44 · FY2014 · GM
Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults
$695,447Robert C Kaplan · Albert Einstein College Of Medicine · R01 · FY2025 · DK
Maladaptive Expression of Metabolic Enzymes and Activity in Heart Failure
$695,444E Douglas Lewandowski · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · HL
Maladaptive Expression of Metabolic Enzymes and Activity in Heart Failure
$695,444E Douglas Lewandowski · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · HL
Counseling older Americans to control hypertension (COACH)
$695,437Gbenga Godwin Ogedegbe · Columbia University Health Sciences · P60 · FY2009 · MD
The Okla Achukma Project
$695,436Jennifer Lemacks · University Of Southern Mississippi · R56 · FY2022 · HL
Leveraging ancestry to map kidney loci
$695,434Nora Franceschini · Univ Of North Carolina Chapel Hill · R01 · FY2021 · MD
Proposal for a Chicago-CRIC Clinical Center
$695,412James P Lash · University Of Illinois At Chicago · U01 · FY2007 · DK
Impact of Interventions on Future Trends in Subnational Burden of Cardiovascular Diseases in the US
$695,396Gregory Andrew Roth · University Of Washington · R01 · FY2020 · HL